Catheter Precision Inc.

AMEX: VTAK · Real-Time Price · USD
0.42
-0.18 (-30.01%)
At close: Jun 12, 2025, 3:59 PM

Catheter Precision Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
600K 481K 420K 399K 436K 439K 442K 328K 195K 104K 28K 19K 24K 1.02M 2.13M 3.35M 4.25M 4.15M
Cost of Revenue
46K 48K 42K 38K 34K 25K 30K 184K 252K 311K 396K 582K 754K 2.18M 3.45M 4.42M 5.59M 5.27M
Gross Profit
554K 433K 378K 361K 402K 414K 412K 144K -57K -207K -368K -563K -730K -1.15M -1.32M -1.07M -1.34M -1.12M
Operating Income
-14.15M -12.19M -11.24M -10.79M -10.66M -14.25M -78.12M -83.74M -85.79M -87.94M -26.96M -27.01M -29.62M -28.4M -30.09M -32.2M -32.58M -35.45M
Interest Income
62K 61K 73K 111K 191K 308K 347K 275K 212K 93K 24K 24K n/a 1K 2K 3K 7K 16K
Pretax Income
-17.78M -15.6M -13.5M -11.68M -9.49M -6.85M -70.57M -78.06M -80.89M -87.77M -26.86M -26.99M -29.6M -26.41M -28.15M -30.3M -30.7M -35.57M
Net Income
-18.9M -18.01M -16.64M -11.68M -9.49M -6.85M -70.57M -78.06M -80.9M -87.77M -26.86M -26.99M -26.53M -23.33M -25.07M -27.23M -30.71M -35.58M
Selling & General & Admin
12.35M 12.18M 11.35M 10.98M 10.84M 9.54M 17.12M 22.35M 23.12M 24.18M 16.25M 12.48M 13.18M 14.44M 16.26M 18.93M 19.65M 23.8M
Research & Development
412K 338K 272K 170K 219K 272K 475K 640K 1.25M 3.52M 6.39M 9.97M 12.19M 12.81M 12.51M 12.2M 11.59M 10.53M
Other Expenses
1.94M 108K n/a n/a n/a n/a 15K 74K 94K 106K 99K 21K 17K 5K -3K -37K -63K -63K
Operating Expenses
14.7M 12.62M 11.62M 11.15M 11.06M 9.82M 17.6M 22.99M 24.38M 27.7M 22.64M 22.45M 25.36M 27.25M 28.76M 31.13M 31.24M 34.33M
Interest Expense
-33K 34K 83K 32K n/a n/a n/a n/a n/a n/a n/a n/a n/a 31K 83K 137K 151K 135K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
14.75M 12.67M 11.66M 11.19M 11.1M 9.84M 17.63M 23.01M 24.39M 27.77M 22.8M 22.96M 26.12M 29.43M 32.22M 35.55M 36.83M 39.6M
Income Tax Expense
1.12M 2.42M 3.14M n/a n/a 5.13M 61.15M 61.16M 61.7M 60.09M 4.07M 4.07M 3.53M 35K 36K 39K -592K -613K
Shares Outstanding (Basic)
13.34M 11.28M 8M 2.05M 757.34K 7.43M 7.03M 6.81M 5.36M 2.73M 2.16M 1.09M 643.24K 400.75K 134.84K 128K 81.78K 58.34K
Shares Outstanding (Diluted)
13.34M 11.28M 8M 2.05M 757.34K 7.43M 7.03M 6.81M 5.36M 2.73M 2.16M 1.09M 643.24K 400.75K 134.84K 128K 81.78K 58.34K
EPS (Basic)
-4.1 -9.29 -9.29 -8.04 -6.31 -1.03 -25.02 -28.7 -32.78 -45.62 -34.98 -92.66 -121.88 -172.93 -283.25 -402.17 -531.64 -1K
EPS (Diluted)
-4.1 -9.29 -9.29 -8.04 -6.31 -1.03 -25.02 -28.7 -32.78 -45.62 -34.98 -92.66 -121.88 -172.93 -283.25 -402.17 -531.64 -1K
EBITDA
-13.71M -11.23M -9.76M -9.93M -8.57M -7.96M -14.82M -20.87M -22.83M -26.05M -22.3M -22.06M -24.97M -26.48M -27.69M -29.67M -29.47M -32.62M
EBIT
-11.24M -13.96M -11.86M -12.02M -10.66M -9.4M -17.18M -22.74M -24.25M -27.73M -22.83M -22.94M -26.09M -27.9M -29.27M -31.39M -31.5M -34.87M
Depreciation & Amortization
1.58M 2.1M 2.09M 2.07M 2.07M 1.15M 2.08M 1.58M 1.14M 1.78M 621K 996K 1.22M 1.41M 1.58M 1.7M 2.03M 2.24M